Latest Pharma Insights
Day One Springs Into Commercial Action With Ojemda Approval
The company is targeting around 200 centers that treat the vast majority of the few thousand pediatric low-grade glioma patients...
Scrip - April 24, 2024
The company is targeting around 200 centers that treat the vast majority of the few thousand pediatric low-grade glioma patients...
Scrip - April 24, 2024
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis...
Medtech Insight - April 24, 2024
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis...
Medtech Insight - April 24, 2024
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency...
Pink Sheet - April 24, 2024
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency...
Pink Sheet - April 24, 2024
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s...
Scrip - April 24, 2024
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s...
Scrip - April 24, 2024
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink...
Pink Sheet - April 24, 2024
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink...
Pink Sheet - April 24, 2024
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold...
HBW Insight - April 24, 2024
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold...
HBW Insight - April 24, 2024
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re...
Scrip - April 24, 2024
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re...
Scrip - April 24, 2024
Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics
CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One...
In Vivo - April 24, 2024
CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One...
In Vivo - April 24, 2024
Adalvo Hails First European Launch Of Prolonged-Release Pregabalin
After the drug’s approval for use in neuropathic pain within the EU last December, Adalvo announced the analgesic’s first European...
Generics Bulletin - April 24, 2024
After the drug’s approval for use in neuropathic pain within the EU last December, Adalvo announced the analgesic’s first European...
Generics Bulletin - April 24, 2024
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed...
Generics Bulletin - April 24, 2024
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed...
Generics Bulletin - April 24, 2024
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years...
Generics Bulletin - April 24, 2024
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years...
Generics Bulletin - April 24, 2024
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to...
Medtech Insight - April 24, 2024
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to...
Medtech Insight - April 24, 2024
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in...
In Vivo - April 24, 2024
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in...
In Vivo - April 24, 2024
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic...
In Vivo - April 24, 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic...
In Vivo - April 24, 2024
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care...
In Vivo - April 24, 2024
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care...
In Vivo - April 24, 2024
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with...
Medtech Insight - April 24, 2024
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with...
Medtech Insight - April 24, 2024
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack...
Scrip - April 24, 2024
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack...
Scrip - April 24, 2024
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific...
Scrip - April 24, 2024
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific...
Scrip - April 24, 2024
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and...
Medtech Insight - April 24, 2024
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and...
Medtech Insight - April 24, 2024
Day One Springs Into Commercial Action With Ojemda Approval
The company is targeting around 200 centers that treat the vast majority of the few thousand pediatric low-grade glioma patients...
Scrip - April 24, 2024
The company is targeting around 200 centers that treat the vast majority of the few thousand pediatric low-grade glioma patients...
Scrip - April 24, 2024
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s...
Scrip - April 24, 2024
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s...
Scrip - April 24, 2024
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re...
Scrip - April 24, 2024
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re...
Scrip - April 24, 2024
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack...
Scrip - April 24, 2024
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack...
Scrip - April 24, 2024
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific...
Scrip - April 24, 2024
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific...
Scrip - April 24, 2024
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency...
Pink Sheet - April 24, 2024
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency...
Pink Sheet - April 24, 2024
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink...
Pink Sheet - April 24, 2024
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink...
Pink Sheet - April 24, 2024
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis...
Medtech Insight - April 24, 2024
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis...
Medtech Insight - April 24, 2024
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to...
Medtech Insight - April 24, 2024
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to...
Medtech Insight - April 24, 2024
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with...
Medtech Insight - April 24, 2024
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with...
Medtech Insight - April 24, 2024
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and...
Medtech Insight - April 24, 2024
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and...
Medtech Insight - April 24, 2024
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold...
HBW Insight - April 24, 2024
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold...
HBW Insight - April 24, 2024
Adalvo Hails First European Launch Of Prolonged-Release Pregabalin
After the drug’s approval for use in neuropathic pain within the EU last December, Adalvo announced the analgesic’s first European...
Generics Bulletin - April 24, 2024
After the drug’s approval for use in neuropathic pain within the EU last December, Adalvo announced the analgesic’s first European...
Generics Bulletin - April 24, 2024
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed...
Generics Bulletin - April 24, 2024
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed...
Generics Bulletin - April 24, 2024
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years...
Generics Bulletin - April 24, 2024
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years...
Generics Bulletin - April 24, 2024
Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics
CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One...
In Vivo - April 24, 2024
CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One...
In Vivo - April 24, 2024
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in...
In Vivo - April 24, 2024
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in...
In Vivo - April 24, 2024
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic...
In Vivo - April 24, 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic...
In Vivo - April 24, 2024
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care...
In Vivo - April 24, 2024
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care...
In Vivo - April 24, 2024